RÉSUMÉ
A 16-year-old castrated male shih tzu dog was brought to the emergency service because of an acute (24 h) history of gagging, coughing, and lethargy. Physical examination revealed dyspnea concurrent with diffuse, bilateral, pulmonary crackles and wheezes. Oxygen saturation, measured with a pulse oximeter, was < 95%. Thoracic radiographs revealed a multifocal alveolar pattern superimposed over a diffuse interstitial pattern with normal heart size. The dog continued to be dyspneic despite oxygen therapy. In accordance with the radiographic findings, further supportive care was recommended. Due to the unknown prognosis and financial constraints, the owner elected humane euthanasia. Necropsy confirmed a pheochromocytoma and lung changes without evidence of congestive heart failure. Findings were consistent with diffuse alveolar damage. These findings correlated with the dog's clinical diagnosis of acute respiratory distress syndrome (ARDS). No other disease processes associated with ARDS were identified. The purpose of this case report is to describe an unusual presentation of ARDS likely associated with a pheochromocytoma and confirmed by necropsy. Acute respiratory distress syndrome associated with a pheochromocytoma has been described in medical literature but has never been reported in veterinary medicine. Key clinical message: Pheochromocytomas should be added to the list of risk factors associated with ARDS in dogs. Dogs with a suspected diagnosis of pheochromocytoma whose owners elect against surgical removal should be closely monitored for an acute onset of respiratory distress, which could suggest the development of ARDS.
Syndrome de détresse respiratoire aiguë associé à un phéochromocytome chez un chien adulteUn chien shih tzu mâle castré de 16 ans a été amené aux services d'urgence en raison d'antécédents aigus (24 heures) de haut-le-coeur, de toux et de léthargie. L'examen physique a révélé une dyspnée concomitante à des crépitements et des respirations sifflantes diffuses, bilatérales et pulmonaires. La saturation en oxygène, mesurée avec un oxymètre de pouls, était < 95 %. Les radiographies thoraciques ont révélé un motif alvéolaire multifocal superposé à un motif interstitiel diffus avec une taille cardiaque normale. Le chien est resté dyspnéique malgré l'oxygénothérapie. Conformément aux résultats radiographiques, des soins de soutien supplémentaires ont été recommandés. En raison du pronostic inconnu et des contraintes financières, le propriétaire a opté pour l'euthanasie sans cruauté. La nécropsie a confirmé un phéochromocytome et des modifications pulmonaires sans signe d'insuffisance cardiaque congestive. Les résultats concordaient avec des lésions alvéolaires diffuses. Ces résultats étaient en corrélation avec le diagnostic clinique du syndrome de détresse respiratoire aiguë (ARDS) du chien. Aucun autre processus pathologique associé à l'ARDS n'a été identifié. Le but de ce rapport de cas est de décrire une présentation inhabituelle de l'ARDS probablement associée à un phéochromocytome et confirmée par la nécropsie. Le syndrome de détresse respiratoire aiguë associé à un phéochromocytome a été décrit dans la littérature médicale mais n'a jamais été rapporté en médecine vétérinaire.Message clinique clé:Les phéochromocytomes doivent être ajoutés à la liste des facteurs de risque associés à l'ARDS chez le chien. Les chiens avec un diagnostic suspecté de phéochromocytome dont les propriétaires choisissent de ne pas procéder à l'ablation chirurgicale doivent être étroitement surveillés pour détecter l'apparition aiguë d'une détresse respiratoire, ce qui pourrait suggérer le développement d'un ARDS.(Traduit par Dr Serge Messier).
Sujet(s)
Tumeurs de la surrénale , Maladies des chiens , Phéochromocytome , , Chiens , Animaux , Phéochromocytome/médecine vétérinaire , Phéochromocytome/complications , Mâle , Maladies des chiens/diagnostic , Maladies des chiens/étiologie , /médecine vétérinaire , /étiologie , Tumeurs de la surrénale/médecine vétérinaire , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/diagnosticRÉSUMÉ
<b>Introduction:</b> Adrenal hemorrhage (AH) is a very rare and potentially life-threatening disease which may be secondary to trauma or of non-traumatic etiology.<b>Aim:</b> The aim of the study was to present the characteristics and management of adrenal hemorrhage and show that adrenal hemorrhage is more common than expected and that the clinical symptoms are not specific.<b>Materials and methods:</b> This retrospective study involved 199 patients with postoperative diagnosis of adrenal hemorrhage.<b>Discussion:</b> The factors identified as potential causes of adrenal hemorrhage are adrenocortical carcinoma, pheochromocytoma, and adrenal adenoma. The study group included 199 patients with postoperative diagnosis of AH. It showed that all patients with postoperative diagnosis had pheochromocytoma (n = 54), adrenal adenoma (n = 68), or adenocarcinoma (n = 17). If we look more careful at the results, we can find only 30% of patients (n = 39) with preoperative diagnosis of AH. This group of 39 patients was prepared for expedited surgery. In this group of patients, the preoperative diagnosis of AH was pheochromocytoma 28% (n = 11), adenocarcinoma (n = 4), and adrenal adenoma (n = 9).<b>Conclusions:</b> Bleeding into adrenal tumors is still an insufficiently understood topic due to its unpredictability and, as can be seen in our material, of varying severity. Out of 199 patients, only 30% (n = 39) were prepared for surgery with a preoperative diagnosis of AH; most of them had pheochromocytoma. We suggest that is very important to prepare patients for surgery with a preoperative diagnosis of AH using α-adrenoreceptor antagonists. Prolongation of the diagnostic process (time between the imaging examination and the surgery) may result in the disease progressing and adrenal bleeding.
Sujet(s)
Tumeurs de la surrénale , Hémorragie , Phéochromocytome , Humains , Femelle , Mâle , Études rétrospectives , Adulte d'âge moyen , Adulte , Hémorragie/étiologie , Hémorragie/diagnostic , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/diagnostic , Phéochromocytome/chirurgie , Phéochromocytome/complications , Phéochromocytome/diagnostic , Sujet âgé , Maladies des surrénales/chirurgie , Maladies des surrénales/diagnostic , SurrénalectomieRÉSUMÉ
RATIONALE: 3P association (3PA) is a rare condition with co-occurrence of pituitary adenoma and pheochromocytoma/paraganglioma. There have been less than a hundred documented cases of 3PA, which can be sporadic or related to genetic mutations. The present case report describes the first Iranian patient with 3PA and a 90th case of 3PA in the available literature. PATIENT CONCERNS AND INTERVENTIONS: A 36-year-old Caucasian male was admitted with headache and sudden increase in blood pressure. An abdominal CT scan revealed a retroperitoneal mass posterior to the inferior vena cava, later removed and diagnosed as a pheochromocytoma. Four years later, he noticed occasional mild headaches and a painless mass on the right side of his neck. The ultrasonography evaluations suggested a carotid body tumor, which was surgically removed. About a month after his second surgery, the severity of the patient's headaches worsened, and he developed right homonymous hemianopia. A brain MRI showed a mass in favor of macroadenoma, craniopharyngioma, or meningioma, and elevated prolactin level led to the diagnosis of macroprolactinoma. DIAGNOSES: Based on the provided history, this patient was diagnosed with 3PA, and a genetic study identified a positive succinate-dehydrogenase-complex subunit b mutation, possibly linked to his family history of carotid body tumor. OUTCOMES: He has remained symptom-free during his visits every 3 months. LESSONS: The number of cases diagnosed with 3PA worldwide is increasing. Using clinical and genetic assessments, we can timely diagnose and adequately monitor individuals with or at risk of 3PA.
Sujet(s)
Tumeurs de la surrénale , Paragangliome , Phéochromocytome , Tumeurs de l'hypophyse , Humains , Mâle , Adulte , Tumeurs de l'hypophyse/diagnostic , Tumeurs de l'hypophyse/complications , Tumeurs de l'hypophyse/génétique , Phéochromocytome/diagnostic , Phéochromocytome/complications , Phéochromocytome/chirurgie , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/chirurgie , Paragangliome/diagnostic , Paragangliome/complications , Paragangliome/génétique , Paragangliome/chirurgie , Adénomes/complications , Adénomes/diagnostic , Tumeurs primitives multiples/diagnostic , Tumeurs primitives multiples/génétique , Tumeurs primitives multiples/anatomopathologieRÉSUMÉ
Metastatic pheochromocytomas and paragangliomas (PPGLs) are frequently associated with skeletal complications. Primary objective: to describe the frequency of adverse skeletal related events (SREs) in PPGL patients with bone metastases (BMs). Secondary objectives: to 1) identify predictive and prognostic factors for SREs and 2) obtain information on the effectiveness of bone resorption inhibitors in reducing SRE risk and improving outcomes in term of survival and SREs time onset. In this retrospective multicenter, multinational study, 294 PPGL patients were enrolled. SREs occurred in 90 patients (31 %). Fifty-five patients (19 %) had bone fractures, 47 (16 %) had spinal cord compression, and 11 (4 %) had hypercalcemia. Twenty-two patients (7 %) had more than one SRE. Sixty-four patients (22 %) underwent surgery, and 136 (46 %) underwent radiotherapy. SREs occurred a median of 4.4 months after diagnosis of BM (range, 0-246.6 months). Independent factors associated with reduced risk of SREs in multivariable analysis were I-131-MIBG radionuclide therapy (hazard ratio [HR], 0.536 [95 % CI, 0.309-0.932]; P = .027) and absence of liver metastases (HR, 0.638 [95 % CI, 0.410-0.992]; P = .046). The median overall survival duration was 5.3 year. In multivariable analysis, age younger than 48 years at PPGL diagnosis (HR, 0.558 [95 % CI, 0.3877-0.806]; P = .002), absence of liver metastases (HR, 0.618 [95 % CI, 0.396-0.965]; P = .034), treatment with bisphosphonates or denosumab (HR, 0.598 [95 % CI, 0.405-0.884]; P = .010), and MIBG radionuclide therapy (HR, 0.444 [95 % CI, 0.274-0.718]; P = .001) were associated with a reduced risk of death. SREs occur frequently and early in bone-metastatic PPGL patients but do not negatively impact survival. MIBG radionuclide therapy and treatment with bone resorption inhibitors are associated with favorable outcome.
Sujet(s)
Tumeurs de la surrénale , Tumeurs osseuses , Paragangliome , Phéochromocytome , Humains , Mâle , Femelle , Adulte d'âge moyen , Tumeurs osseuses/secondaire , Tumeurs osseuses/complications , Phéochromocytome/complications , Phéochromocytome/anatomopathologie , Phéochromocytome/mortalité , Études rétrospectives , Tumeurs de la surrénale/secondaire , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/mortalité , Tumeurs de la surrénale/thérapie , Adulte , Sujet âgé , Paragangliome/complications , Paragangliome/anatomopathologie , Paragangliome/mortalité , Jeune adulte , Syndrome de compression médullaire/étiologie , Fractures osseuses/étiologie , Adolescent , Sujet âgé de 80 ans ou plus , Hypercalcémie/étiologie , Facteurs de risque , Agents de maintien de la densité osseuse/usage thérapeutique , PronosticRÉSUMÉ
Ectopic ACTH syndrome (EAS) remains one of the most demanding diagnostic and therapeutic challenges for endocrinologists. Thymic neuroendocrine tumors account for 5%-10% of all EAS cases. We report a unique case of a 31-year-old woman with severe EAS caused by primary metastatic combined large-cell neuroendocrine carcinoma and atypical carcinoid of the thymus. The patient presented with severe hypercortisolemia, which was successfully controlled with continuous etomidate infusion. Complex imaging initially failed to detect thymic lesion; however, it revealed a large, inhomogeneous, metabolically active left adrenal mass infiltrating the diaphragm, suspected of primary disease origin. The patient underwent unilateral adrenalectomy, which resulted in hypercortisolemia resolve. The pathology report showed an adenoma with adrenal infarction and necrosis. The thymic tumor was eventually revealed a few weeks later on follow-up imaging studies. Due to local invasion and rapid progression, only partial resection of the thymic tumor was possible, and the patient was started on radio- and chemotherapy.
Sujet(s)
Tumeurs de la surrénale , Carcinome neuroendocrine , Syndrome de Cushing , Tumeurs du thymus , Humains , Femelle , Adulte , Tumeurs du thymus/complications , Tumeurs du thymus/anatomopathologie , Tumeurs du thymus/chirurgie , Syndrome de Cushing/étiologie , Syndrome de Cushing/anatomopathologie , Carcinome neuroendocrine/anatomopathologie , Carcinome neuroendocrine/secondaire , Carcinome neuroendocrine/complications , Carcinome neuroendocrine/chirurgie , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/secondaire , Tumeurs de la surrénale/anatomopathologie , Syndrome de sécrétion ectopique d'ACTH/diagnostic , Syndrome de sécrétion ectopique d'ACTH/anatomopathologie , Syndrome de sécrétion ectopique d'ACTH/étiologie , Surrénalectomie , Tumeurs primitives multiples/anatomopathologie , Tumeurs primitives multiples/complicationsSujet(s)
Tumeurs de la surrénale , Hormone corticotrope , Syndrome de Cushing , Humains , Syndrome de Cushing/diagnostic , Syndrome de Cushing/étiologie , Syndrome de Cushing/complications , Hormone corticotrope/métabolisme , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/diagnostic , Femelle , Adulte d'âge moyen , Tomographie par émission de positons couplée à la tomodensitométrie , Adulte , Mâle , Adénomes/complications , Adénomes/diagnosticRÉSUMÉ
Pheochromocytoma is a tumor derived from neural crest cells able to produce sympathomimetic substances and, hence, a particular clinical picture. It is responsible for less than 1% of high blood pressure cases, with an estimated incidence between 0.4 and 0.6 cases per 100,000 people each year, and an average survival of seven years. Pheochromocytoma is a solid tumor with a high genetic component, as heritability can reach 40%. Once diagnosed, its treatment and prognosis are partly conditioned by the associated pathogenic variants that can be documented, especially those related to RET, SDHx, VHL, and NF1 genes. We present the case of a young woman with abdominal pain and high blood pressure, who was found to have a pheochromocytoma. Genetic testing detected a rare and recently discovered pathogenic variant: the SDHA:c.1A>C (p.Met1Leu). The patient responded adequately to the surgical treatment and continued the follow-up without documented recurrences. The diagnostic approach for pheochromocytoma patients must start with a clinical suspicion, followed by metabolite measurement in blood and urine, and finally, imaging. Currently, technology development allows precision medicine applicability. In this case of pheochromocytoma, recent developments in precision medicine resulted in the detection of associated genetic components involving the patient and her family. Adequate screening of the index patient is required for documenting pathogenic variants and better characterizing the disease.
El feocromocitoma es un tumor derivado de las células de la cresta neural con la capacidad de producir sustancias simpaticomiméticas y, por ende, un cuadro clínico particular. Causa menos del 1 % de los casos de hipertensión arterial sistémica y su incidencia se estima entre 0,4 y 0,6 casos por 100.000 personas cada año, con una supervivencia media de siete años. De todos los tumores sólidos, el feocromocitoma tiene un mayor componente genético, que puede heredarse hasta en el 40 % de los casos. Una vez diagnosticada la enfermedad, se debe definir el tratamiento y el pronóstico, en parte condicionados por las variantes genéticas asociadas, en especial RET, SDHx, VHL y NF1. Se presenta el caso de una mujer joven con dolor abdominal e hipertensión arterial sistémica, a quien se le diagnosticó feocromocitoma. Al secuenciar el exoma, se identificó una variante patogénica extremadamente rara y de reciente descubrimiento: SDHA: c.1A>C (p.Met1Leu). La paciente respondió adecuadamente al tratamiento quirúrgico y continuó en seguimiento sin recurrencias. El abordaje diagnóstico de los pacientes con feocromocitoma comienza con la sospecha clínica, seguida de la medición de determinados metabolitos en sangre y orina, y, finalmente, los estudios de imagenología. Los desarrollos tecnológicos actuales permiten la aplicación de la medicina de precisión en este campo. En este caso de feocromocitoma, se identificó un componente genético importante que no solo afecta al paciente, sino también, a sus familiares. La tamización adecuada del caso índice permite identificar mutaciones y caracterizar mejor la enfermedad.
Sujet(s)
Tumeurs de la surrénale , Hypertension artérielle , Phéochromocytome , Humains , Phéochromocytome/complications , Phéochromocytome/génétique , Phéochromocytome/diagnostic , Femelle , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/génétique , Tumeurs de la surrénale/diagnostic , Hypertension artérielle/étiologie , Hypertension artérielle/complications , Colombie , Paragangliome/génétique , Paragangliome/complications , Paragangliome/diagnostic , AdulteRÉSUMÉ
BACKGROUND: Functioning adrenal adenoma during pregnancy is rare, and the diagnosis is challenging owing to unspecific symptoms and restricted investigations. The obstetric outcomes of patients who undergo surgery during pregnancy or who receive only medical treatment are poorly described. OBJECTIVE: The aim was to investigate the associations between functioning adrenal adenomas and obstetric outcomes. METHODS: A retrospective study was performed in a tertiary center over 20 years. The clinical characteristics, management and obstetric outcomes of the diagnosed pregnant women were reviewed. RESULTS: A total of 12 women were diagnosed with functioning adrenal adenomas during pregnancy from January 2002 to September 2022. Eight women had cortisol-secreting adrenal adenomas, two had excessive catecholamine secretion, and two had primary aldosteronism. The initial symptoms of adrenal adenoma during pregnancy included hypertension or preeclampsia, gestational diabetes mellitus or prepregnancy diabetes mellitus, hypokalemia and ecchymosis. Four women underwent adrenalectomy during pregnancy, while 8 women received only medical therapy. Preterm birth occurred in all patients who received medicine, whereas 1 patient who underwent surgery experienced preterm birth. Among the 8 women in the medical treatment group, 3 had neonates who died. CONCLUSIONS: Once hypertension, hyperglycemia and hypokalemia occur during the 1st or 2nd trimester, pregnant women with adrenal adenomas should be evaluated via laboratory and imaging examinations. The maternal and fetal outcomes were unpredictable owing to the severity of adrenal adenoma, particularly in patients who received only medical treatment. Adrenalectomy should be recommended during pregnancy.
Sujet(s)
Tumeurs de la surrénale , Complications tumorales de la grossesse , Issue de la grossesse , Centres de soins tertiaires , Humains , Femelle , Grossesse , Adulte , Études rétrospectives , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/chirurgie , Adénomes/complications , Adénomes/chirurgie , Surrénalectomie , Adénome corticosurrénalien/complications , Adénome corticosurrénalien/chirurgie , Adénome corticosurrénalien/anatomopathologie , Pronostic , Jeune adulteRÉSUMÉ
OBJECTIVE: To investigate the impact of adrenalectomy on hypertension in patients with nonfunctional adrenal tumors. SUBJECTS AND METHODS: Between January 2020 and October 2022, patients with adrenal lesions were retrospectively screened for nonfunctional adrenal tumors at the Zhongnan Hospital of Wuhan University. All patients underwent detailed endocrinological examination and computed tomography to characterize the lesions. One year after discharge, follow-up blood pressure (BP) was assessed and compared to the blood pressure on admission. Univariate analysis and multivariate regression analysis were performed to determine factors predicting favorable hypertension outcomes after adrenalectomy. RESULTS: A total of 309 patients were found to be eligible, including 123 who underwent adrenalectomy. Patients who underwent adrenalectomy were stratified into two groups: (Bancos I (2022) Adrenal Incidentalomas: Insights Into Prevalence. Ann Intern Med 175:1481-1482. https://doi.org/10.7326/M22-2600 ) those with improved hypertension (n = 71), and (Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J et al. (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1-42. https://doi.org/10.1093/ejendo/lvad066 ) those without improved hypertension (n = 52). In contrast, the blood pressure levels of conservatively treated patients remained relatively stable 1 year after discharge. Univariate analysis and multivariate regression analysis showed that body mass index (BMI) and duration of hypertension were significantly different between the hypertension improvement group and the non-improvement group (p < 0.05). CONCLUSION: Adrenalectomy has been shown to be effective in improving hypertension in certain patients with nonfunctional adrenal tumors. BMI and duration of hypertension were independent factors associated with favorable hypertension outcomes after adrenalectomy.
Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Hypertension artérielle , Humains , Surrénalectomie/méthodes , Études rétrospectives , Mâle , Adulte d'âge moyen , Femelle , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/complications , Hypertension artérielle/épidémiologie , Hypertension artérielle/complications , Sujet âgé , Adulte , Résultat thérapeutiqueRÉSUMÉ
BACKGROUND: Congenital adrenal hyperplasia (CAH) encompassed a bunch of autosomal recessive disorders characterized by impaired cortisol levels due to an enzymatic deficiency in steroid synthesis. In adult male patients with CAH, a frequent complication related to poor disease control is the development of ectopic adrenocortical tissue in the testes, named testicular adrenal rest tumors (TART). Conversely, ovarian adrenal rest tumors (OART) in females are extremely rare and adrenal rests in sites other than gonads are so uncommon to have been described only few times in literature. CASE PRESENTATION: We report a case of a male patient with untreated CAH and oncologic history of pleomorphic sarcoma who presented with massive bilateral adrenal enlargement and adrenal rest tumors in peri-lumbar and peri-cecal sites, which mimicked metastasis from sarcoma. CONCLUSIONS: The development of massive adrenal enlargement and ectopic adrenal rest tumors in sites other than gonads, even if very uncommon, should be suspected in patients with CAH and prolonged periods of undertreatment.
Sujet(s)
Hyperplasie congénitale des surrénales , Choristome surrénalien , Humains , Hyperplasie congénitale des surrénales/complications , Hyperplasie congénitale des surrénales/anatomopathologie , Hyperplasie congénitale des surrénales/diagnostic , Mâle , Choristome surrénalien/anatomopathologie , Choristome surrénalien/diagnostic , Choristome surrénalien/étiologie , Diagnostic différentiel , Sarcomes/diagnostic , Sarcomes/anatomopathologie , Adulte , Tumeurs de la surrénale/anatomopathologie , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/secondaire , PronosticRÉSUMÉ
BACKGROUND: Inflammatory rhabdomyoblastic tumors are relatively recently recognized soft tissue tumors with a low malignant potential. Here, we present a case of concurrent inflammatory rhabdomyoblastic tumor (IRMT), adrenal pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1 (NF1). To our knowledge, this is the first time that this constellation of tumors has been described in the literature. CASE PRESENTATION: A female patient in her late 20s with known NF1 was diagnosed with an inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a short succession. IRMT was found to harbor a near-haploid genome and displayed a typical immunohistochemical profile as well as a focal aberrant p53 expression pattern. CONCLUSIONS: This case report strengthens the theory that defects in the tumor suppressor NF1 play a central role in the pathogenesis of inflammatory rhabdomyoblastic tumors and that IRMT may be part of the spectrum of neurofibromatosis type 1 related tumors.
Sujet(s)
Tumeurs de la surrénale , Hamartomes , Neurofibromatose de type 1 , Phéochromocytome , Humains , Neurofibromatose de type 1/complications , Neurofibromatose de type 1/diagnostic , Neurofibromatose de type 1/anatomopathologie , Femelle , Hamartomes/anatomopathologie , Hamartomes/diagnostic , Phéochromocytome/anatomopathologie , Phéochromocytome/complications , Phéochromocytome/diagnostic , Tumeurs de la surrénale/anatomopathologie , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/diagnostic , Adulte , Immunohistochimie , Maladies pulmonaires/anatomopathologie , Maladies pulmonaires/diagnostic , Neurofibromine-1/génétique , Marqueurs biologiques tumoraux/analyse , Marqueurs biologiques tumoraux/génétiqueSujet(s)
Tumeurs de la surrénale , Hémorragie , Mélanome , Tumeurs cutanées , Humains , Mélanome/secondaire , Hémorragie/étiologie , Tumeurs de la surrénale/secondaire , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/imagerie diagnostique , Tumeurs cutanées/secondaire , Tumeurs cutanées/anatomopathologie , Mâle , Tomodensitométrie , Adulte d'âge moyen , Maladies des surrénales/diagnostic , Maladies des surrénales/imagerie diagnostiqueRÉSUMÉ
The following case discusses the surgical considerations for a patient presenting with cardiogenic shock secondary to a phaeochromocytoma crisis with stress cardiomyopathy. The patient underwent an interval laparoscopic adrenalectomy. Pneumoperitoneum insufflation was performed at lower pressures; manipulation of the adrenal tumour was minimised, and the adrenal vein was ligated early. However, as intraoperative blood pressure (BP) remained elevated and rising, further gentle dissection revealed an aberrant inferior phrenic vein draining the adrenal nodule. BP was finally reduced following ligation of the inferior phrenic vein, demonstrating the clinical significance of an unusual dual venous drainage from the adrenal nodule in this patient.
Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Phéochromocytome , Humains , Phéochromocytome/chirurgie , Phéochromocytome/complications , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/complications , Surrénalectomie/méthodes , Syndrome de tako-tsubo , Femelle , Choc cardiogénique/étiologie , Adulte d'âge moyen , Laparoscopie/méthodes , Soins périopératoires/méthodes , MâleSujet(s)
Tumeurs de la surrénale , Pancréatite , Phéochromocytome , Humains , Phéochromocytome/complications , Phéochromocytome/diagnostic , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/diagnostic , Pancréatite/étiologie , Maladie aigüe , Mâle , Femelle , Surrénalectomie , Adulte d'âge moyenRÉSUMÉ
CONTEXT: The impact of abnormal cortisol secretion on cognitive functions in patients with mild autonomous cortisol secretion (MACS) remains uncertain. OBJECTIVE: To assess cognitive functions, determine serum brain-derived neurotrophic factor (BDNF) concentration in patients with MACS, and investigate the association between cognitive subdomains and BDNF. METHODS: We prospectively recruited 84 participants-28 patients with MACS, 28 patients with nonfunctional adrenal adenoma (NFAA), and 28 control subjects matched for age, gender, body mass index (BMI), visceral adiposity, and educational level. The serum BDNF concentration of participants was measured. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-focused interviews and Montreal Cognitive Assessments (MoCA) were carried out by an experienced psychiatrist. RESULTS: Patients with MACS had a higher serum BDNF concentration than the NFAA (P = .001), while that of patients with NFAA was lower than the controls (P = .044). Linear regression analysis revealed BMI and morning cortisol after overnight 1 mg dexamethasone (DST) were mostly associated with BDNF (P < .05). No significant difference was found in MoCA scores between MACS and NFAA groups (P = .967), whereas those were lower than the control group (P = .004). When the cognitive subdomains were examined separately, MACS group performed higher memory score than NFAA (P = .045), but lower language scores than both the NFAA (P = .024) and control groups (P < .001). In the whole group, BDNF concentration was positively correlated with memory score (r = 0.337, P = .002), whereas DST was negatively correlated with language score (r = -0.355, P = .008). CONCLUSION: Low-grade hypercortisolism is associated with elevated BDNF concentrations, which may be a protective factor for memory function in patients with MACS relative to those with NFAA.
Sujet(s)
Facteur neurotrophique dérivé du cerveau , Cognition , Hydrocortisone , Humains , Facteur neurotrophique dérivé du cerveau/sang , Mâle , Femelle , Hydrocortisone/sang , Adulte d'âge moyen , Cognition/physiologie , Adulte , Études prospectives , Études cas-témoins , Dysfonctionnement cognitif/sang , Dysfonctionnement cognitif/étiologie , Tumeurs de la surrénale/sang , Tumeurs de la surrénale/complications , Sujet âgéRÉSUMÉ
BACKGROUND: Hypertension (HT) is one of the most common manifestations in patients with catecholamine-secreting neuroendocrine tumors. Although the cardiovascular manifestations of these tumors have been described, there have been no large-scale investigations of the profile of HT and changes in cardiac structure and function that occur in patients with pheochromocytomas and paragangliomas (PPGL). MATERIALS AND METHODS: In this study, we investigated the prevalence of HT and left ventricular remodeling (LVR) in a cohort of 598 patients who underwent surgery for PPGL at our center between January 2001 and April 2022. Information on demographics, reason for hospitalization, medical history, biochemical parameters, findings on echocardiography, and tumor characteristics were recorded. The LVR index was compared according to whether or not there was a history of HT. RESULTS: The average age was 47.07 ± 15.07 years, and 277 (46.32%) of the patients were male. A history of HT was found in 423 (70.74%) of the 598 patients. Paraganglioma was significantly more common in the group with HT (26.00% vs. 17.71%, P = 0.030) and significantly less likely to be found incidentally during a health check-up in this group (22.93% vs. 59.43%, P < 0.001). Among 365 patients with complete echocardiography data, left ventricular mass index (86.58 ± 26.70 vs. 75.80 ± 17.26, P < 0.001) and relative wall thickness (0.43 ± 0. 08 vs. 0.41 ± 0.06, P = 0.012) were significantly higher in patients with PPGL and a history of HT. The proportions with left ventricular hypertrophy (LVH) (19.40% vs. 8.25%, P = 0.011) and LVR (53.73% vs. 39.18%, P = 0.014) were also higher when there was a history of HT. After adjusting for age, gender, body mass index, alcohol consumption, smoking status, diabetes, stroke, creatinine level, tumor location, and tumor size, a history of HT was significantly correlated with LVH (odds ratio 2.71, 95% confidence interval 1.18-6.19; P = 0.018) and LVR (odds ratio 1.83, 95% confidence interval 1.11-3.03; P = 0.018). CONCLUSION: HT is common in patients with PPGL (70.74% in this cohort). PPGL without a history of HT is more likely to be found incidentally (59.43% in our cohort). HT is associated with LVR in PPGL patients with complete echocardiography data. These patients should be observed carefully for cardiac damage, especially those with a history of HT.
Sujet(s)
Tumeurs de la surrénale , Hypertension artérielle , Paragangliome , Phéochromocytome , Fonction ventriculaire gauche , Remodelage ventriculaire , Humains , Phéochromocytome/complications , Phéochromocytome/épidémiologie , Phéochromocytome/imagerie diagnostique , Phéochromocytome/chirurgie , Mâle , Femelle , Adulte d'âge moyen , Tumeurs de la surrénale/épidémiologie , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/imagerie diagnostique , Adulte , Paragangliome/épidémiologie , Paragangliome/complications , Paragangliome/imagerie diagnostique , Hypertension artérielle/épidémiologie , Prévalence , Études rétrospectives , Facteurs de risque , Appréciation des risques , Sujet âgé , Pression sanguineSujet(s)
Tumeurs de la surrénale , Hémangiome , Lupus érythémateux disséminé , Humains , Lupus érythémateux disséminé/complications , Lupus érythémateux disséminé/diagnostic , Hémangiome/complications , Hémangiome/chirurgie , Hémangiome/anatomopathologie , Femelle , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/imagerie diagnostique , Tumeurs de la surrénale/anatomopathologie , AdulteRÉSUMÉ
Background: A recent cross-sectional study showed that both comorbidities and mortality in patients with adrenal incidentaloma (AI) are tied to sex. However, few longitudinal studies evaluated the development of arterial hypertension, hyperglycemia, dyslipidemia and bone impairment in patients with AI. The aim of this study is to analyze the impact of sex in the development of these comorbidities during long-term follow-up. Methods: We retrospectively evaluated 189 patients (120 females, 69 males) with AI, from four referral centers in Italy and Croatia. Clinical characteristics, comorbidities and cortisol after 1-mg dexamethasone suppression test (1-mg DST) were assessed at baseline and at last follow-up visit (LFUV). Median follow-up was 52 (Interquartile Range 25-86) months. Results: The rates of arterial hypertension and hyperglycemia increased over time both in females (65.8% at baseline versus 77.8% at LFUV, p=0.002; 23.7% at baseline versus 39.6% at LFUV, p<0.001; respectively) and males (58.0% at baseline versus 69.1% at LFUV, p=0.035; 33.8% at baseline versus 54.0% at LFUV, p<0.001; respectively). Patients were stratified in two groups using 1.8 µg/dl as cut-off of cortisol following 1-mg DST: non-functional adrenal tumors (NFAT) and tumors with mild autonomous cortisol secretion (MACS). In the NFAT group (99 patients, females 62.6%), at baseline, we did not observe any difference in clinical characteristics and comorbidities between males and females. At LFUV, males showed a higher frequency of hyperglycemia than females (57.6% versus 33.9%, p=0.03). In the MACS group (89 patients, females 64.0%), at baseline, the prevalence of hypertension, hyperglycemia and dyslipidemia was similar between sexes, despite females were younger (60, IQR 55-69 versus 67.5, IQR 61-73, years; p=0.01). Moreover, females presented higher rates of bone impairment (89.3% versus 54.5%, p=0.02) than males. At LFUV, a similar sex-related pattern was observed. Conclusion: Patients with AI frequently develop arterial hypertension and hyperglycemia and should be periodically checked for these comorbidities, regardless of sex. In patients with MACS, the lack of difference between sexes in the frequency of cardiometabolic comorbidities despite that females are younger, and the higher frequency of bone impairment in females, suggest a sex-specific effect of cortisol.
Sujet(s)
Tumeurs de la surrénale , Comorbidité , Hypertension artérielle , Humains , Femelle , Mâle , Tumeurs de la surrénale/épidémiologie , Tumeurs de la surrénale/sang , Tumeurs de la surrénale/complications , Adulte d'âge moyen , Études rétrospectives , Sujet âgé , Hypertension artérielle/épidémiologie , Facteurs sexuels , Hyperglycémie/épidémiologie , Hyperglycémie/sang , Dyslipidémies/épidémiologie , Études de suivi , Italie/épidémiologie , Études transversalesRÉSUMÉ
Ectopic ACTH-secreting pheochromocytoma is a very rare cause of Cushing´s syndrome, posing diagnostic and therapeutic challenges. We here report the case of a female patient with suspected severe Cushing´s syndrome associated with melanoderma, arterial hypertension resistant to triple therapy and unbalanced diabetes treated with insulin therapy. Biologically, urinary ethoxylated, 24-hour urinary free cortisol and ACTH were very high. Imaging showed a 3.5 cm left adrenal mass. The patient underwent left adrenalectomy after medical preparation, with good clinico-biological outcome. Anatomopathological examination confirmed the diagnosis of pheochromocytoma. This case study highlights the importance of measuring methoxylated derivatives in any patient with ACTH-dependent Cushing´s syndrome associated with an adrenal mass. The aim is to ensure early treatment and avoid life-threatening complications.
Sujet(s)
Tumeurs de la surrénale , Hormone corticotrope , Phéochromocytome , Adulte , Femelle , Humains , Adulte d'âge moyen , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/métabolisme , Tumeurs de la surrénale/complications , Surrénalectomie/méthodes , Hormone corticotrope/métabolisme , Syndrome de Cushing/étiologie , Syndrome de Cushing/diagnostic , Hydrocortisone/métabolisme , Hypertension artérielle/étiologie , Phéochromocytome/diagnostic , Phéochromocytome/métabolisme , Phéochromocytome/complicationsRÉSUMÉ
Selective venous sampling (SVS), an invasive radiographic procedure that depends on contrast media, holds a unique role in diagnosing and guiding the treatment of certain types of secondary hypertension, particularly in patients who may be candidates for curative surgery. The adrenal venous sampling (AVS), in particular, is established as the gold standard for localizing and subtyping primary aldosteronism (PA). Throughout decades of clinical practice, AVS could be applied not only to PA but also to other endocrine diseases, such as adrenal Cushing syndrome (ACS) and Pheochromocytomas (PCCs). Notably, the application of AVS in ACS and PCCs remains less recognized compared to PA, with the low success rate of catheterization, the controversy of results interpretation, and the absence of a standardized protocol. Additionally, the AVS procedure necessitates enhancements to boost its success rate, with several helpful but imperfect methods emerging, yet continued exploration remains essential. We also observed renal venous sampling (RVS), an operation akin to AVS in principle, serves as an effective means of diagnosing renin-dependent hypertension, aiding in the identification of precise sources of renin excess and helping the selection of surgical candidates with renin angiotensin aldosterone system (RAAS) abnormal activation. Nonetheless, further basic and clinical research is needed. Selective venous sampling (SVS) can be used in identifying cases of secondary hypertension that are curable by surgical intervention. Adrenal venous sampling (AVS) and aldosterone measurement for classificatory diagnosis of primary aldosteronism (PA) are established worldwide. While its primary application is for PA, AVS also holds the potential for diagnosing other endocrine disorders, including adrenal Cushing's syndrome (ACS) and pheochromocytomas (PCCs) through the measurements of cortisol and catecholamine respectively. In addition, renal venous sampling and renin measurement can help to diagnose renovascular hypertension and reninoma.